Xencor (XNCR) Tax Provisions (2016 - 2026)
Xencor's (XNCR) quarterly Tax Provisions came in at $300000.0 in Q1 2026, down 25.0% year-on-year from $400000.0 in Q1 2025, and down 87.43% on a QoQ basis from $2.4 million in Q4 2025.
Xencor (XNCR) Tax Provisions (2016 - 2026) Analysis & Trends
Xencor (XNCR) has 8 years of Tax Provisions data on file, last reported at $300000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions fell 25.0% year-over-year to $300000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 20.82% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 54.85% from the prior year.
- Tax Provisions for Q1 2026 stood at $300000.0, down from $2.4 million in the prior quarter.
- Over the last five years, Tax Provisions for XNCR reached as high as $13.7 million in Q4 2023 and fell as low as -$415000.0 in Q4 2022.
- Historically, Tax Provisions has averaged $2.3 million across 5 years, with a median of $744000.0 in 2022.
- Across the five-year window, Tax Provisions jumped 3392.05% in 2023 and slumped 88.16% in 2024, its largest moves.
- Year by year, Tax Provisions stood at -$415000.0 in 2022, then soared by 3392.05% to $13.7 million in 2023, then slumped by 88.16% to $1.6 million in 2024, then jumped by 47.62% to $2.4 million in 2025, then sank by 87.43% to $300000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $300000.0 in Q1 2026, $2.4 million in Q4 2025, and -$250000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 2.39 Mn |
| Jun 30, 2025 | -250,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 13.66 Mn |
| Dec 31, 2022 | -415,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Dec 31, 2019 | 5.11 Mn |
| Sep 30, 2019 | -350,000.00 |
| Jun 30, 2019 | 50,000.00 |
| Mar 31, 2019 | 900,000.00 |
| Dec 31, 2017 | -1.09 Mn |
| Sep 30, 2017 | 173,000.00 |
| Jun 30, 2017 | 280,000.00 |
| Mar 31, 2017 | 170,000.00 |
| Dec 31, 2016 | -159,000.00 |
| Sep 30, 2016 | -598,000.00 |
| Jun 30, 2016 | 1.75 Mn |